Status:
NOT_YET_RECRUITING
Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica
Lead Sponsor:
University Hospital, Brest
Conditions:
Inflammatory Rheumatism
18-FDG
Eligibility:
All Genders
18-110 years
Brief Summary
Study of the diagnostic performance of 18-FDG PET scores in Polymyalgia rheumatica and comparaison with others inflammatories diseases.
Detailed Description
Polymyalgia Rheumatica is difficult to diagnostic because symptoms are non specific and many diseases can be differential diagnosis (cancer, infections, others rheumatisms...). PET-CT is more often u...
Eligibility Criteria
Inclusion
- Having 18-FDG PET-CT between 2012 and 2024
- Diagnosis of inflammatory rheumatism by specialist doctor
- Adult without opposition to use there data for research
- Affiliate to social security system
Exclusion
- Refusal participation
- Patient under juridic protection
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT06558357
Start Date
September 1 2024
End Date
December 31 2024
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Brest
Brest, France, 29609